The Effect of 25-OH-Vitamin-D3 Substitution in Patients With Malignant and Immune-hematologic Diseases

NCT01518959 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

31

Enrollment

OTHER

Sponsor class

Stopped Insufficient recruitment rate; technical issues with sample storage

Conditions

Chronic Lymphoid Leukemia

Interventions

DRUG: Cholecalciferol
DRUG: oleum neutralicum

Sponsor

Semmelweis University